BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37923509)

  • 1. Management of uterine fibroids: Approach to medical treatment.
    Huerga López C; Gutiérrez Alagüero A; Cristóbal García I
    Med Clin (Barc); 2023 Oct; 161 Suppl 1():S15-S21. PubMed ID: 37923509
    [No Abstract]   [Full Text] [Related]  

  • 2. Ulipristal acetate in uterine fibroids.
    Galliano D
    Fertil Steril; 2015 Feb; 103(2):359-60. PubMed ID: 25555419
    [No Abstract]   [Full Text] [Related]  

  • 3. Uterine fibroids associated with infertility.
    Van Heertum K; Barmat L
    Womens Health (Lond); 2014 Nov; 10(6):645-53. PubMed ID: 25482490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uterine fibroids and their treatment].
    Hrubosová E
    Ceska Gynekol; 2011 Apr; 76(2):152-7. PubMed ID: 21650001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evidence-based guideline for the management of uterine fibroids.
    Farquhar C; Arroll B; Ekeroma A; Fentiman G; Lethaby A; Rademaker L; Roberts H; Sadler L; Strid J;
    Aust N Z J Obstet Gynaecol; 2001 May; 41(2):125-40. PubMed ID: 11453261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Uterine fibroids].
    Poulsen BB; Munk T; Rudnicki M; Ravn P
    Ugeskr Laeger; 2017 Oct; 179(43):. PubMed ID: 29076451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment of subserosal fibroids: the cons].
    Marret H; Ouldamer L
    Gynecol Obstet Fertil; 2011; 39(7-8):454-7. PubMed ID: 21752689
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of uterine fibroids.
    al-Taher H; Farquharson RG
    Br J Hosp Med; 1993 Jul 14-Aug 17; 50(2-3):133-6. PubMed ID: 8353665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice. Uterine fibroids.
    Stewart EA
    N Engl J Med; 2015 Apr; 372(17):1646-55. PubMed ID: 25901428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroids and medical therapy: bridging the gap from selective progesterone receptor modulators to gonadotropin-releasing hormone antagonist.
    Donnez J; Dolmans MM
    Fertil Steril; 2020 Oct; 114(4):739-741. PubMed ID: 32854931
    [No Abstract]   [Full Text] [Related]  

  • 11. Sarcomas and the conservative management of uterine fibroids: a cause for concern?
    Dover RW; Ferrier AJ; Torode HW
    Aust N Z J Obstet Gynaecol; 2000 Aug; 40(3):308-12. PubMed ID: 11065039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonography and magnetic resonance imaging of uterine fibroids.
    Mayer DP; Shipilov V
    Obstet Gynecol Clin North Am; 1995 Dec; 22(4):667-725. PubMed ID: 8786877
    [No Abstract]   [Full Text] [Related]  

  • 13. [Uterine fibroids--therapy from the point of view of the gynaecologist].
    Middendorf K; Burges A; Strauss A; Hepp H
    Radiologe; 2003 Aug; 43(8):615-23. PubMed ID: 14504761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study.
    Yerushalmi GM; Gilboa Y; Jakobson-Setton A; Tadir Y; Goldchmit C; Katz D; Seidman DS
    Fertil Steril; 2014 Feb; 101(2):496-500. PubMed ID: 24220703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the effects of gonadotropin-releasing hormone agonist therapy in uterine leiomyoma by T1 contrast-enhanced magnetic resonance imaging sequences.
    Kadowaki M; Murakami T; Morita J; Terada Y; Yaegashi N; Okamura K
    Fertil Steril; 2002 May; 77(5):1081-2. PubMed ID: 12009376
    [No Abstract]   [Full Text] [Related]  

  • 16. Ulipristal acetate for use in moderate to severe symptoms of uterine fibroids.
    Talaulikar VS; Manyonda I
    Womens Health (Lond); 2014 Nov; 10(6):565-70. PubMed ID: 25482483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of fibroids should be tailored to the patient.
    King R; Overton C
    Practitioner; 2011 Mar; 255(1738):19-23, 2-3. PubMed ID: 21510505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient shrinkage of a uterine leiomyosarcoma treated with GnRH agonist for a presumed uterine leiomyoma: comparison of magnetic resonance imaging finding before and during GnRH agonist treatment.
    Kawamura N; Iwanaga N; Hada S; Maeda K; Sumi T; Ishiko O; Ogita S
    Oncol Rep; 2001; 8(6):1255-7. PubMed ID: 11605044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative treatment of uterine leiomyoma with the antiestrogen antiprogesterone R-2323.
    Coutinho EM
    Int J Gynaecol Obstet; 1981 Oct; 19(5):357-60. PubMed ID: 6120104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term medical management of uterine fibroids with ulipristal acetate.
    Donnez J; Donnez O; Matule D; Ahrendt HJ; Hudecek R; Zatik J; Kasilovskiene Z; Dumitrascu MC; Fernandez H; Barlow DH; Bouchard P; Fauser BC; Bestel E; Loumaye E
    Fertil Steril; 2016 Jan; 105(1):165-173.e4. PubMed ID: 26477496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.